SMi Group reports: 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will be returning to London next week.
Payers continue to play an important role in market access. Products are increasingly being rejected for reimbursement, adversely affecting the market share of these products. (Sourse: Medgadget, Sept 2016).
SMi’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will gather leading industry experts next week in London to discuss the questions such as:
- What strategies can pharmaceutical companies implement in order to overcome the challenges?
- What are the current trends in Health Technology Assessment?
- What are the pricing and reimbursement policies in the US, UK, Turkey, Nordic countries and Japan?
Alexander Natz, Secretary General, EUCOPE will be presenting current challenges in European market access, pricing and reimbursement at the day 1 of the event. Alexander will discuss a better understanding of pricing issues: Euripid Database, EUnetHTA and differential pricing vs international reference pricing.
Simone Breikopf, Head HEOR, Governmental and Public Affairs, Alcon will be focusing on current trends in Health Technology Assessment (HTA): synergy between payers and European HTA bodies, current requirements for harmonisation of HTA and challenges associated with this, early dialogue for medical devices.
Furthermore, an updates from U.S., Turkey, Japan and Nordic countries will be presented. Donald Macarthur, Adviser, Proceutica will present the Turkish story on market access. Updates from the U.S. will be discussed by Ken Walsh, Global Pricing & Market Access Associate, Navigant. Spotlight address: Japan 2016 P&R reforms will be presented by Donald Macarthur, Global Pharmaceutical Business Analys. Rasmus Jensen, Owner; Former Director and Head of Market Access, Drewes Jensen Consult; Lundbeck will be providing a Nordic update – market access outlook.
The event will feature two exclusive post-conference workshops:
A: HTA and reimbursement decisions for innovative medicines. Workshop Leader: Patrick Mollon, Former Director Global Health Economics & Outcomes Research, Novartis; HEOR Director, PMHE2020
B: Managing the global to local challenge (Get all required information for HTA submission) Workshop Leader: Janice Haigh, Practice Leader, Quintiles
The event is only 1 week away - places are filling fast!
For more information please visit: www.pharmaceuticalpricing.co.uk
For media enquiries please contact Anna Serazetdinova on +44 20 7827 6180 or email@example.com
For delegate enquiries contact Fateja Begum +44 (0) 20 7827 6184 or email firstname.lastname@example.org
For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: email@example.com
---- END ----
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
For more information:
Last updated on: 03/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.